Sage Therapeutics shares owned by DAFNA Capital Management
Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by DAFNA Capital Management
from 13F filings
Historical chart of DAFNA Capital Management investment in Sage Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sage Therapeutics held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sage Therapeutics by DAFNA Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $860k | 108k | 7.95 |
| 2024-12-31 | $588k | 108k | 5.43 |
| 2024-09-30 | $781k | 108k | 7.22 |
| 2024-06-30 | $1.3M | 116k | 10.86 |
| 2023-12-31 | $5.3M | 245k | 21.67 |
| 2023-06-30 | $8.5M | 180k | 47.02 |
| 2023-03-31 | $7.6M | 180k | 41.96 |
| 2022-12-31 | $6.9M | 180k | 38.14 |
| 2022-09-30 | $7.1M | 180k | 39.16 |
| 2022-06-30 | $5.8M | 180k | 32.30 |
| 2022-03-31 | $6.0M | 180k | 33.10 |
| 2021-12-31 | $7.7M | 180k | 42.54 |
| 2021-09-30 | $8.0M | 180k | 44.31 |
| 2021-06-30 | $9.7M | 170k | 56.81 |
| 2021-03-31 | $14M | 181k | 74.85 |
| 2020-12-31 | $16M | 181k | 86.51 |
| 2020-09-30 | $9.7M | 158k | 61.12 |
| 2020-06-30 | $6.9M | 165k | 41.58 |
| 2020-03-31 | $4.7M | 165k | 28.72 |
| 2019-12-31 | $9.0M | 125k | 72.19 |
| 2019-09-30 | $18M | 125k | 140.29 |
| 2019-06-30 | $23M | 124k | 183.09 |
| 2019-03-31 | $20M | 124k | 159.05 |
| 2018-12-31 | $10M | 104k | 95.79 |
| 2018-09-30 | $14M | 99k | 141.25 |
| 2018-06-30 | $15M | 96k | 156.53 |
| 2018-03-31 | $15M | 94k | 161.07 |
| 2017-12-31 | $4.7M | 29k | 164.72 |